The European Medicines Agency’s (EMA) Adverse Drug Reaction Database now reports 46,999 deaths and 4,731,833 injuries from COVID-19 vaccines (details below).
In the United States, the Vaccine Adverse Event Registry System (VAERS) now reports 29,790 deaths and 1,357,940 injuries from COVID-19 vaccines. ( Source )
https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=CAT&EVENTS=ON&VAX=COVID19
A 2011 report by Harvard Pilgrim Health Care, Inc. for the US Department of Health and Human Services (HHS) indicated that less than 1% of all post-vaccination adverse events are reported to VAERS.
46,999 dead and 4,731,833 injured at EudraVigilance
The European database (EEA and non-EEA countries) of reports of suspected drug reactions is EudraVigilance verified by the European Medicines Agency (EMA), now reporting 46,999 deaths and 4,731,833 injuries after five experimental injections of COVID-19:
Of the total number of injuries recorded, almost half (2,143,362) are injured fallen down.
” Gravity provides information about the suspected side effect; can be qualified as “serious” if it corresponds to a medical event that led to the death is life-threatening, requires hospitalization, results in another significant medical condition or prolongation of an existing hospitalization, results in persistent or significant disability or incapacity, or is a birth defect/birth defect. »
It’s a lot of work to compile every reaction with injuries and deaths, because there is no room in the system EudraVigilance that we found that compiles all the results.
Here is the summary data through July 30, 2022.
Total reactions for Tozinameran mRNA vaccine (code BNT162b2, Comirnaty) of BioNTech/ Pfizer: 22,191 dead and 2,448,297 injured as of 07/30/2022
- 72.801 Blood and lymphatic system disorders included 315 deaths
- 84,773 Cardiac disorders included 3,205 deaths
- 768 Congenital, familial and genetic disorders included 69 deaths
- 31.480 Ear and labyrinth disorders included 17 deaths
- 3.122 Endocrine disorders included 12 victims
- 35,427 Eye disorders included 57 deaths
- 172.416 Gastrointestinal disorders included 887 deaths
- 628,578 General disorders and administration site conditions included 6,073 deaths
- 2,795 Hepatobiliary disorders included 126 deaths
- 26,839 Immune system disorders included 140 deaths
- 164,955 Infections and infestations included 2,300 deaths
- 43,540 injuries, poisonings and procedural complications, included 504 deaths
- 58,107 surveys included 608 deaths
- 15.362 Metabolism and nutrition disorders included 389 deaths
- 274,956 Musculoskeletal and connective tissue disorders, included 314 deaths
- 2,852 Benign, malignant and unspecified tumors (including cysts and polyps) included 269 deaths
- 376 478 Nervous system disorders included 2,369 deaths
- 3,350 Pregnancy, puerperal and perinatal conditions included 84 deaths
- 319 product issues included 4 killed
- 42,571 Psychiatric disorders included 250 victims
- 8,846 Kidney and urinary disorders included 332 deaths
- 102.925 Reproductive system and breast disorders, included 9 victims
- 99.625 Respiratory, thoracic and mediastinal disorders included 2,361 deaths
- 106.932 Disorders of skin and subcutaneous tissue included 203 deaths
- 6,403 Social circumstances included 28 deaths
- 26,452 Surgical and medical interventions included 283 deaths
- 55.625 Vascular disorders included 983 deaths
Total reactions to Moderna’s SPIKEVAX/mRNA-1273 (CX-024414) mRNA vaccine: 12,285 deaths and 782,763 injuries as of 07/30/2022
- 20,959 Blood and lymphatic system disorders included 140 deaths
- 27.417 Cardiac disorders included 1,351 deaths
- 244 Congenital, familial and genetic disorders included 15 victims
- 9.266 Ear and labyrinth disorders included 8 victims
- 819 Endocrine disorders, included 6 victims
- 10,432 Eye disorders included 41 deaths
- 61.275 Gastrointestinal disorders included 467 deaths
- 206,650 General disorders and administration site conditions included 3,942 deaths
- 1,041 Hepatobiliary disorders included 66 deaths
- 8,808 Immune system disorders included 43 deaths
- 34,547 Infections and infestations included 1,123 deaths
- 11,502 Injuries, poisonings and procedural complications, included 236 deaths
- 17,404 surveys included 409 deaths
- 6.277 Metabolism and nutrition disorders included 291 deaths
- 97.363 Musculoskeletal and connective tissue disorders, included 249 deaths
- 954 Neoplasms benign, malignant and unspecified (including cysts and polyps) , incl. 105 deaths
- 128.358 Nervous system disorders included 1,185 deaths
- 1,089 Pregnancy, puerperal and perinatal conditions included 12 victims
- 127 Product Issues included 3 killed
- 12,948 Psychiatric disorders included 198 deaths
- 4.108 Kidney and urinary disorders included 236 deaths
- 21,794 Reproductive system and breast disorders included 9 victims
- 31.925 Respiratory, thoracic and mediastinal disorders included 1,303 deaths
- 40,979 Disorders of skin and subcutaneous tissue included 110 deaths
- 3,143 Social circumstances included 45 victims
- 7,090 Surgical and medical interventions included 224 deaths
- 16.244 Vascular disorders included 468 deaths
Total Oxford/Astra Zeneca AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) vaccine reactions: 9,427 deaths and 1,328,069 injuries as of 07/30/2022
- 15.427 Blood and lymphatic system disorders included 335 deaths
- 23,779 Cardiac disorders included 991 deaths
- 281 Familial and genetic congenital disorders, included 11 deaths
- 14.975 Ear and labyrinth disorders included 8 victims
- 834 Endocrine disorders, included 7 killed
- 22.260 Eye disorders included 33 deaths
- 119,238 Gastrointestinal disorders included 501 deaths
- 357 237 General disorders and administration site conditions included 2,198 deaths
- 1,202 Hepatobiliary disorders included 84 deaths
- 6,727 Immune system disorders included 47 deaths
- 58.172 Infections and infestations included 800 dead
- 15.172 Poisoning by wounds and procedural complications, included 232 deaths
- 32,384 inquiries included 226 deaths
- 14.713 Metabolism and nutrition disorders included 150 deaths
- 191.884 Musculoskeletal and connective tissue disorders, included 197 deaths
- 915 Neoplasms benign, malignant and unspecified (including cysts and polyps) , incl. 55 victims
- 263.649 Nervous system disorders included 1,356 deaths
- 718 Postpartum pregnancy and perinatal conditions included 23 deaths
- 207 product issues included 1 death
- 23,695 Psychiatric disorders included 84 deaths
- 4,860 Kidney and urinary disorders included 101 deaths
- 18.374 Reproductive system and breast disorders included 3 killed
- 46,318 Thoracic and mediastinal respiratory disorders included 1,254 deaths
- 58.025 Disorders of skin and subcutaneous tissue included 77 deaths
- 2,440 Social circumstances included 11 deaths
- 3,147 Surgical and medical procedures included 43 deaths
- 31,436 Vascular disorders included 599 deaths
Total JANSSEN (AD26.COV2.S) COVID-19 vaccine reactions of Johnson & Johnson : 3,096 dead and 169,472 injured as of 07/30/2022
- 1,687 Blood and lymphatic system disorders incl. 69 deaths
- 3,734 Heart conditions included 258 deaths
- 59 Congenital, familial and genetic disorders included 3 killed
- 1,846 Ear and labyrinth disorders included 3 killed
- 153 Endocrine disorders included 2 deaths
- 2,223 Eye disorders included 16 deaths
- 11,562 Gastrointestinal disorders included 123 deaths
- 46.545 General disorders and administration site conditions included 858 deaths
- 212 Hepatobiliary disorders included 22 deaths
- 793 Immune system disorders, included 12 victims
- 14,808 Infections and infestations included 261 deaths
- 1,594 Injuries, poisonings and procedural complications, included 37 deaths
- 7,694 inquiries included 164 deaths
- 1,064 Metabolism and nutrition disorders included 84 deaths
- 21.229 Musculoskeletal and connective tissue disorders, included 71 deaths
- 148 Neoplasms benign, malignant and unspecified (including cysts and polyps) included 12 victims
- 29.060 Nervous system disorders included 298 deaths
- 126 Pregnancy, puerperal and perinatal conditions included 1 death
- 35 Product Issues
- 2,483 Psychiatric disorders included 35 victims
- 722 Kidney and urinary disorders included 50 victims
- 4.066 Reproductive system and breast disorders included 6 victims
- 5,970 Respiratory, thoracic and mediastinal disorders included 390 deaths
- 5.188 Skin and subcutaneous tissue disorders included 16 deaths
- 690 Social Circumstances included 7 killed
- 1,201 Surgical and medical interventions included 101 deaths
- 4,580 Vascular disorders included 197 deaths
Total reactions to Novavax’s NUVAXOVID(NVX-COV2373) COVID-19 vaccine: 0 deaths and 3,096 injuries as of 07/30/2022
- 72 Blood and lymphatic system disorders
- 182 Cardiac disorders
- 1 Congenital, familial and genetic disorders
- 42 Ear and labyrinth disorders
- 1 Endocrine disorders
- 60 Eye conditions
- 225 Gastrointestinal disorders
- 727 General disorders and administration site conditions
- 3 Hepatobiliary disorders
- 27 Immune System Disorders
- 170 Infections and infestations
- 28 Injury, Poisoning and Procedural Complications
- 83 Investigations
- 17 Disorders of metabolism and nutrition
- 416 Musculoskeletal and connective tissue disorders
- 1 Benign, malignant and unspecified tumors (including cysts and polyps)
- 577 Nervous system disorders
- 2 Pregnancy, puerperal and perinatal conditions
- 1 Problems with the product
- 49 Psychiatric disorders
- 19 Kidney and urinary disorders
- 58 Reproductive System and Breast Disorders
- 165 Respiratory, thoracic and mediastinal disorders
- 207 Skin and subcutaneous tissue disorders
- 5 Social circumstances
- 26 Surgical and medical procedures
- 68 Vascular disorders
*These totals are estimates based on reports sent to EudraVigilance . Totals can be much higher depending on the percentage of reported adverse events. Some of these reports may also be submitted to national adverse reaction databases, such as the US VAERS database and the UK Yellow Card system. Deaths are grouped by symptoms, and some deaths may result from multiple symptoms.